NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,665 | +0.9% | 3,207 | 0.0% | 0.03% | +4.0% |
| Q2 2023 | $323,619 | +6.4% | 3,207 | -3.0% | 0.02% | +4.2% |
| Q1 2023 | $304,244 | +1.4% | 3,307 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $300,011 | +22.0% | 3,307 | +2.2% | 0.02% | +14.3% |
| Q3 2022 | $246,000 | -8.6% | 3,236 | +1.5% | 0.02% | -4.5% |
| Q2 2022 | $269,000 | +2.7% | 3,187 | +6.7% | 0.02% | 0.0% |
| Q4 2021 | $262,000 | +3.6% | 2,986 | -3.2% | 0.02% | -8.3% |
| Q3 2021 | $253,000 | -15.7% | 3,086 | -5.9% | 0.02% | -14.3% |
| Q2 2021 | $300,000 | +2.0% | 3,278 | -4.8% | 0.03% | -3.4% |
| Q1 2021 | $294,000 | -11.4% | 3,445 | -2.0% | 0.03% | -12.1% |
| Q4 2020 | $332,000 | -10.5% | 3,515 | -17.5% | 0.03% | -19.5% |
| Q3 2020 | $371,000 | -45.1% | 4,263 | -44.9% | 0.04% | -47.4% |
| Q2 2020 | $676,000 | -4.4% | 7,738 | -9.8% | 0.08% | -17.9% |
| Q1 2020 | $707,000 | -25.7% | 8,580 | -14.6% | 0.10% | -8.7% |
| Q4 2019 | $952,000 | +1.2% | 10,052 | -7.2% | 0.10% | -4.6% |
| Q3 2019 | $941,000 | -7.2% | 10,830 | -2.5% | 0.11% | -7.6% |
| Q2 2019 | $1,014,000 | -3.7% | 11,104 | +1.4% | 0.12% | -6.3% |
| Q1 2019 | $1,053,000 | +8.1% | 10,953 | -3.5% | 0.13% | -3.1% |
| Q4 2018 | $974,000 | -4.2% | 11,353 | -3.9% | 0.13% | +13.0% |
| Q3 2018 | $1,017,000 | +11.0% | 11,808 | -2.6% | 0.12% | +4.5% |
| Q2 2018 | $916,000 | -16.7% | 12,126 | -10.9% | 0.11% | -18.5% |
| Q1 2018 | $1,100,000 | -18.1% | 13,604 | -15.0% | 0.14% | -13.5% |
| Q4 2017 | $1,343,000 | -13.0% | 15,998 | -11.0% | 0.16% | -16.6% |
| Q3 2017 | $1,543,000 | -8.2% | 17,971 | -10.7% | 0.19% | -7.4% |
| Q2 2017 | $1,680,000 | -3.1% | 20,130 | -13.8% | 0.20% | -0.5% |
| Q1 2017 | $1,734,000 | -16.9% | 23,348 | -18.5% | 0.20% | -11.7% |
| Q4 2016 | $2,087,000 | -12.1% | 28,647 | -4.8% | 0.23% | -14.5% |
| Q3 2016 | $2,375,000 | -4.8% | 30,077 | -0.6% | 0.27% | -7.2% |
| Q2 2016 | $2,496,000 | +14.9% | 30,252 | +0.9% | 0.29% | +9.4% |
| Q1 2016 | $2,173,000 | -16.8% | 29,989 | -1.3% | 0.26% | -19.2% |
| Q4 2015 | $2,613,000 | -14.0% | 30,371 | -8.1% | 0.33% | -18.6% |
| Q3 2015 | $3,039,000 | -8.3% | 33,062 | -1.9% | 0.40% | 0.0% |
| Q2 2015 | $3,314,000 | -0.0% | 33,698 | +0.2% | 0.40% | +0.2% |
| Q1 2015 | $3,315,000 | +10.6% | 33,618 | +3.9% | 0.40% | +7.5% |
| Q4 2014 | $2,998,000 | -1.1% | 32,350 | +0.5% | 0.37% | -3.9% |
| Q3 2014 | $3,030,000 | +0.2% | 32,195 | -3.6% | 0.39% | +2.6% |
| Q2 2014 | $3,024,000 | +6.1% | 33,405 | -0.3% | 0.38% | +3.6% |
| Q1 2014 | $2,850,000 | +3.0% | 33,519 | -2.6% | 0.37% | +1.9% |
| Q4 2013 | $2,767,000 | +3.8% | 34,425 | -0.9% | 0.36% | -4.0% |
| Q3 2013 | $2,665,000 | +7.8% | 34,744 | -0.6% | 0.37% | +4.5% |
| Q2 2013 | $2,472,000 | +16.4% | 34,969 | +17.3% | 0.36% | +10.5% |
| Q1 2013 | $2,123,000 | – | 29,799 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |